Appointed
Darren Lopez
Director
BHIC ·
BioScience Health Innovations, Inc.
Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.
Ready 8-Ks
10
Latest filing
April 2, 2026, 7:59 PM ET
Top materiality
0.85
Event mix
other_material ×5 · m_and_a ×3 · leadership ×2
Sentiment
0 pos · 1 neg · 9 neu
Executive change
recent →
Recent 8-K filings for BHIC
Highest-materiality recent filing
Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director
- Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.
- Ivan Homici resigned as director, President, Treasurer, and Secretary on July 29, 2021; Justin Earl replaced him in all roles.
-
Issued 34,371,100 shares (85.39% of post-closing shares) to Best Labs shareholders for all of Best's shares; deal closed March 10, 2023.
-
Nowtransit appoints John Chymboryk as CFO effective March 21, 2023
John Chymboryk appointed Chief Financial Officer, effective immediately on March 21, 2023.
-
Nowtransit completes reverse merger with Best Labs; new CEO and board appointed
Nowtransit issued 34,371,100 shares (85.39% of outstanding) for 100% of Best Labs common stock.
-
Nowtransit to issue 85.39% stake for Best Labs acquisition in share exchange
Nowtransit acquires Best Labs via share exchange; Best shareholders receive 34.37M shares (85.39% post-exchange) for 100% of Best.
-
Justin Earl purchased 2,800,000 shares (51.3% of common stock) from former majority shareholder Ivan Homici for $28,000 on April 2, 2021.
Executive changes
Departed
Justin Earl
Chief Executive Officer
BHIC ·
BioScience Health Innovations, Inc.
Justin Earl tendered his resignation as the sole officer of the Company.
Appointed
John Chymboryk
Director
BHIC ·
BioScience Health Innovations, Inc.
Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.
Appointed
Darren Lopez
Chief Executive Officer
BHIC ·
BioScience Health Innovations, Inc.
Darren López was appointed as the Chief Executive Officer of the Company.
Appointed
John Chymboryk
Chief Financial Officer
BHIC ·
BioScience Health Innovations, Inc.
On March 21, 2023, Nowtransit Inc. (the “Company”) appointed Mr. John Chymboryk as Chief Financial Officer of the Company, effective immediately.
Appointed
Darren Lopez
Chief Executive Officer
BHIC ·
BioScience Health Innovations, Inc.
Darren López was appointed as the Chief Executive Officer of the Company
Appointed
John Chymboryk
Director
BHIC ·
BioScience Health Innovations, Inc.
Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors
Departed
Justin Earl
Officer
BHIC ·
BioScience Health Innovations, Inc.
Effective upon the Closing, Justin Earl tendered his resignation as the sole officer of the Company
Appointed
Darren Lopez
Director
BHIC ·
BioScience Health Innovations, Inc.
Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors
Departed
Ivan Homici
President
BHIC ·
BioScience Health Innovations, Inc.
On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
Appointed
Justin Earl
President
BHIC ·
BioScience Health Innovations, Inc.
On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
Materiality & sentiment trend
Max materiality 0.85 · Median 0.57 · Most common event other_material